Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study

Ying L. Liu, Qin Zhou, Alexia Iasonos, S. Dennis, Oliver Zivanovic, Yukio Sonoda, Ginger J. Gardner, Vance Broach, Roisin E. O’Cearbhaill, Jason Konner, Rachel N. Grisham, Carol Aghajanian, Nadeem R. Abu‐Rustum, William P. Tew, Kara Long Roche